[1] |
Vianna ME, Horz HP, Conrads G,et al. Effect of root canal procedures on endotoxins and endodontic pathogens[J]. Oral Microbiol Immunol,2007,22(6):411-418.
|
[2] |
He W, Qu T, Yu Q,et al. LPS induces IL-8 expression through TLR4,MyD88,NF-kappaB and MAPK pathways in human dental pulp stem cells[J]. Int Endod J,2013,46(2):128-136.
|
[3] |
Chang J, Zhang C, Tani-Ishii N,et al. NF-kappaB activation in human dental pulp stem cells by TNF and LPS[J]. J Dent Res,2005,84(11):994-998.
|
[4] |
Fleiss B, Nilsson MK, Blomgren K,et al. Neuroprotection by the histone deacetylase inhibitor trichostatin A in a model of lipopolysaccharide-sensitised neonatal hypoxic-ischaemic brain injury[J]. J Neuroinflammation,2012(9):70.
|
[5] |
Elaut G, Rogiers V, Vanhaecke T. The pharmaceutical potential of histone deacetylase inhibitors[J]. Curr Pharm Des,2007,13(25):2584-2620.
|
[6] |
Marks PA. Histone deacetylase inhibitors:a chemical genetics approach to understanding cellular functions[J]. Biochim Biophys Acta,2010,1799(10-12):717-725.
|
[7] |
Thangavel J, Samanta S, Rajasingh S,et al. Epigenetic modifiers reduce inflammation and modulate macrophage phenotype during endotoxemia-induced acute lung injury[J]. J Cell Sci,2015,128(16):3094-3105.
|
[8] |
Cho JS, Kang JH, Han IH,et al. Antiallergic effects of trichostatin a in a murine model of allergic rhinitis[J]. Clin Exp Otorhinolaryngol,2015,8(3):243-249.
|
[9] |
Tsaprouni LG, Ito K, Adcock IM,et al. Suppression of lipopolysaccharide- and tumour necrosis factor-alpha-induced interleukin (IL)-8 expression by glucocorticoids involves changes in IL-8 promoter acetylation[J]. Clin Exp Immunol,2007,150(1):151-157.
|
[10] |
Duncan HF, Smith AJ, Fleming GJ,et al. Histone deacetylase inhibitors induced differentiation and accelerated mineralization of pulp-derived cells[J]. J Endod,2012,38(3):339-345.
|
[11] |
Duncan HF, Smith AJ, Fleming GJ,et al. Histone deacetylase inhibitors epigenetically promote reparative events in primary dental pulp cells[J]. Exp Cell Res,2013,319(10):1534-1543.
|
[12] |
Khan AU, Krishnamurthy S. Histone modifications as key regulators of transcription[J]. Front Biosci,2005(10):866-872.
|
[13] |
Qiao Y, Giannopoulou EG, Chan CH,et al. Synergistic activation of inflammatory cytokine genes by interferon-γ-induced chromatin remodeling and toll-like receptor signaling[J]. Immunity,2013,39(3):454-469.
|
[14] |
Kim ES, Lee JK. Histone deacetylase inhibitors decrease the antigen presenting activity of murine bone marrow derived dendritic cells[J]. Cell Immunol,2010,262(1):52-57.
|
[15] |
Doherty R, O′Farrelly C, Meade KG. Epigenetic regulation of the innate immune response to LPS in bovine peripheral blood mononuclear cells(PBMC)[J]. Vet Immunol Immunopathol,2013,154(3-4):102-110.
|
[16] |
Ghizzoni M, Haisma HJ, Maarsingh H,et al. Histone acetyltransferases are crucial regulators in NF-κB mediated inflammation[J]. Drug Discov Today,2011,16(11-12):504-511.
|
[17] |
Wollebo HS, Bellizzi A, Cossari DH,et al. Epigenetic regulation of polyomavirus JC involves acetylation of specific lysine residues in NF-κB p65[J]. J Neurovirol,2015,21(6):679-687.
|
[18] |
Ziesché E, Kettner-Buhrow D, Weber A,et al. The coactivator role of histone deacetylase 3 in IL-1-signaling involves deacetylation of p65 NF-κB[J]. Nucleic Acids Res,2013,41(1):90-109.
|
[19] |
Sato T, Kotake D, Hiratsuka M,et al. Enhancement of inflammatory protein expression and nuclear factor κB(NF-κB)activity by trichostatin A(TSA)in OP9 preadipocytes[J]. PLoS One,2013,8(3):e59702.
|
[20] |
He X, Wei Z, Zhou E,et al. Baicalein attenuates inflammatory responses by suppressing TLR4 mediated NF-κB and MAPK signaling pathways in LPS-induced mastitis in mice[J]. Int Immunopharmacol,2015,28(1):470-476.
|